Director/PDMR Shareholding

RNS Number : 7833Q

Barclays PLC

17 April 2009

 



17 April 2009

Director/PDMR Shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a)

1.

The independent trustee of the Barclays Group (ESAS) Employees' Benefit Trust (the 'ESAS Trust') notified Barclays PLC ('the Company') on 17 April 2009 that it had on 16 April 2009 exercised its discretion and released shares following provisional allocations made in previous years by the trustee over the Company's ordinary shares. Of these shares the following were released to directors and PDMRs of the Company:

Directors/ PDMRS	Shares released to Director/ PDMR	Shares sold on behalf of  Director/PDMR  to satisfy  withholding  liabilities¹	Share  price at award² (pence)	Market price at date of release (pence)	Shares retained by Director/ PDMR
RE Diamond Jr	4,260,538	0	510³	210	4,260,538
CG Lucas	41,682	17,116	724	210	24,566
JS Varley	48,172	19,781	491	210	28,391

2.

The independent trustee of the ESAS Trust notified the Company on 16 April 2009 that it had on 15 April 2009 granted rights in the form of nil cost options to the directors and PDMRs of the Company listed below under the ESAS to acquire ordinary shares in the Company. The ESAS options are exercisable from grant until 21 February 2011 and are granted over a proportion of the shares which were provisionally allocated by the trustee under ESAS on 21 March 2006 to the directors and PDMRs listed below.

The number of shares under option includes an additional number of shares which have been accrued in respect of dividends received by the trustee since March 2006. The total exercise price payable on any exercise of an ESAS option is £1.

Director        Number of shares granted under option to Director/PDMR 

JS Varley        100,924

         The revised total shareholding for each director following these transactions is as follows:

Director	Beneficial Holding
RE Diamond Jr	10,127,503
CG Lucas	100,604
JS Varley	621,657

¹ RE Diamond Jr paid for his tax and social security obligations from personal funds to cover the liability due on the 
  release of shares by the ESAS Trust.

² The price shown reflects the average price paid by the independent trustee of the ESAS Trust to purchase 
  ordinary shares to satisfy the award.

   ³ This is a weighted average price as the awards were made over a number of years.

---

 

END

 

 

RDSGUUGUCUPBGAM